Cargando…
Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer’s disease mouse model
There is increasing evidence that inducing neuronal mitophagy can be used as a therapeutic intervention for Alzheimer’s disease. Here, we screen a library of 2024 FDA-approved drugs or drug candidates, revealing UMI-77 as an unexpected mitophagy activator. UMI-77 is an established BH3-mimetic for MC...
Autores principales: | Cen, Xufeng, Chen, Yanying, Xu, Xiaoyan, Wu, Ronghai, He, Fusheng, Zhao, Qingwei, Sun, Qiming, Yi, Cong, Wu, Jie, Najafov, Ayaz, Xia, Hongguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665171/ https://www.ncbi.nlm.nih.gov/pubmed/33184293 http://dx.doi.org/10.1038/s41467-020-19547-6 |
Ejemplares similares
-
Targeting MCL1 to induce mitophagy is a potential therapeutic strategy for Alzheimer disease
por: Cen, Xufeng, et al.
Publicado: (2020) -
Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model
por: Xu, Xiaoyan, et al.
Publicado: (2021) -
Correction to: Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model
por: Xu, Xiaoyan, et al.
Publicado: (2021) -
Mitophagy Regulates Neurodegenerative Diseases
por: Cen, Xufeng, et al.
Publicado: (2021) -
ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
por: Wu, Youqian, et al.
Publicado: (2021)